Company: SRPT
Filing Date: 2025-07-25
Form Type: SCHEDULE 13G/A
Source: 0001104659-25-070926
Chunk: 0

Company: Sarepta Therapeutics, Inc.
Filing Date: 2025-07-25
Form: SCHEDULE 13G/A
Chunk 0
---
 connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. |

| SIGNATURE |                                                                                                                                                                |
|           | After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. |

| D. E. Shaw & Co., L.P. |

| Signature:   /s/ Daniel R. Marcus                            
   Name/Title:  Daniel R. Marcus / Chief Compliance Officer   
   Date:        07/25/2025                                    |

| David E. Shaw |

| Signature:   /s/ Daniel R. Marcus                                      
   Name/Title:  Daniel R. Marcus / Attorney-in-Fact for David E. Shaw   
   Date:        07/25/2025                                              |

Comments accompanying signature:This Schedule 13G amendment is being filed solely to include the Joint Filing Agreement, by and among the Reporting Persons, dated July 25, 2025 (Exhibit 2), which was omitted from the initial filing due to a technical issue encountered by our third-party filing service. Exhibit 1: Power of Attorney, granted by David E. Shaw relating to D. E. Shaw & Co., Inc., in favor of the signatories hereto, among others, dated August 1, 2024.